|
1
|
Meyers PA, Schwartz CL, Krailo M, et al: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 23:2004–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bacci G, Forni C, Longhi A, et al: Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27-year experience in a single institution. J Surg Oncol. 96:118–123. 2007.PubMed/NCBI
|
|
3
|
Jawad MU, Cheung MC, Clarke J, et al: Osteosarcoma: Improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol. 137:597–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mialou V, Philip T, Kalifa C, et al: Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome - the French pediatric experience. Cancer. 104:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hegyi M, Semsei AF, Jakab Z, et al: Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer. 57:415–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stokkel MP, Linthorst MF, Borm JJ, et al: A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma. J Cancer Res Clin Oncol. 128:393–399. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yeh CS, Wang JY, Cheng TL, et al: Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by microarray-bioinformatics analysis. Cancer Let. 233:297–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hess D and Igal RA: Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells. Exp Biol Med (Maywood). 236:707–713. 2011.PubMed/NCBI
|
|
9
|
Alo PL, Amini M, Piro F, et al: Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma. Anticancer Res. 27:2523–2527. 2007.PubMed/NCBI
|
|
10
|
Walter K, Hong SM, Nyhan S, et al: Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev. 18:2380–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okawa Y, Hideshima T, Ikeda H, et al: Fatty acid synthase is a novel therapeutic target in multiple myeloma. Br J Haematol. 141:659–671. 2008. View Article : Google Scholar
|
|
12
|
Migita T, Ruiz S, Fornari A, et al: Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst. 101:519–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu ZL, Wang G, Shu Y, et al: Enhanced antitumor activity of epirubicin combined with cerulenin in osteosarcoma. Mol Med Report. 5:326–330. 2012.PubMed/NCBI
|
|
14
|
Orita H, Coulter J, Tully E, et al: Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors. Clin Cancer Res. 14:2458–2464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coleman DT, Bigelow R and Cardelli JA: Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Mol Cancer Ther. 8:214–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saati GE and Archer MC: Inhibition of fatty acid synthase and Sp1 expression by 3,3′-diindolylmethane in human breast cancer cells. Nutr Cancer. 63:790–794. 2011.
|
|
17
|
Notarnicola M, Pisanti S, Tutino V, et al: Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr. 6:63–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Notarnicola M, Messa C, Refolo MG, et al: Polyunsaturated fatty acids reduce fatty acid synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression and promote apoptosis in HepG2 cell line. Lipids Health Dis. 10:102011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zecchin KG, Rossato FA, Raposo HF, et al: Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis. Lab Invest. 91:232–240. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carvalho MA, Zecchin KG, Seguin F, et al: Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer. 123:2557–2565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murata S, Yanagisawa K, Fukunaga K, et al: Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice. Cancer Sci. 101:1861–1865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu ZL, Zhou Y, Luo QF, et al: Inhibition fatty acid synthase suppress osteosarcoma cell invasion and migration. Indian J Pathol Microbiol. 55:163–169. 2012. View Article : Google Scholar
|
|
23
|
Kim VN, Han J and Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sarkar S, Dey BK and Dutta A: MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell. 21:2138–2149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Forrest AR, Kanamori-Katayama M, Tomaru Y, et al: Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 24:460–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosa A, Ballarino M, Sorrentino A, et al: The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA. 104:19849–19854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakashima T, Jinnin M, Etoh T, et al: Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: Its implications to therapy. PLoS One. 5:e143342010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chamorro-Jorganes A, Araldi E, Penalva LO, et al: MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol. 31:2595–2606. 2011. View Article : Google Scholar
|
|
32
|
Ghosh G, Subramanian IV, Adhikari N, et al: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest. 120:4141–4154. 2010.PubMed/NCBI
|
|
33
|
Xu J, Li Y, Wang F, et al: Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. Apr 2–2012.(Epub ahead of print). View Article : Google Scholar
|
|
34
|
Faraoni I, Laterza S, Ardiri D, et al: MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. J Hematol Oncol. 5:262012. View Article : Google Scholar
|
|
35
|
Rentoft M, Fahlén J, Coates PJ, et al: miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. Int J Oncol. 38:61–69. 2011.PubMed/NCBI
|
|
36
|
Hussein K, Büsche G, Muth M, et al: Expression of myelopoiesis associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia. Ann Hematol. 90:307–313. 2011. View Article : Google Scholar
|
|
37
|
Guo ST, Jiang CC, Wang GP, et al: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene. Jun 18–2012.(Epub ahead of print). View Article : Google Scholar
|
|
38
|
Wang X, Wang J, Ma H, et al: Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol. 29:919–927. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Selbach M, Schwanhäusser B, Thierfelder N, et al: Widespread changes in protein synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
